EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Post-translational switch of DHCR24 acetylation sustains sterol synthesis and promotes HCC via the 7-ketocholesterol/p62 axis

Yunfei Zhou, Xinxin Yang, Jianwen Xu, Yidi Wu, Yin Fu, Yihong Dong, Xun Yang, Qiang Fu, Chenxu Guo, Yunjing Hou, Shuyuan Chang, Jun Yan und 11 weitere

Cell Reports · 2025

DOI: 10.1016/j.celrep.2025.116640 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Reports, 2025. Verfasst von Yunfei Zhou und 22 weiteren Autor:innen. Beteiligte Einrichtung: NHC Key Laboratory of Molecular Probes and Targeted Diagnosis and Therapy, The Fourth Hospital of Harbin Medical University, Harbin, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Ketocholesterols, Oxidoreductases Acting on CH-CH Group Donors. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China, Harbin Medical University, Ministry of Human Resources and Social Security of the People's Republic of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dysregulated cholesterol synthesis fuels cancer progression, but its precise role in hepatocellular carcinoma (HCC) remains unclear. Here, we identify elevated acetylation of 24-dehydrocholesterol reductase (DHCR24) at Lys254 as a hallmark of HCC. Both total DHCR24 and its K254 acetylation independently predict poor patient survival. Acetylation stabilizes DHCR24, sustaining hepatic cholesterol synthesis and promoting tumorigenesis. Mechanistically, DHCR24 acetylation enhances 7-ketocholesterol accumulation, which upregulates p62 and drives HCC growth in vitro and in vivo. Pharmacologic inhibition of DHCR24 expression and acetylation with the US Food and Drug Administration (FDA)-approved drug irbesartan suppresses cell proliferation and reduces tumor burden in xenograft and carcinogen-induced mouse models. Reduced p62 expression parallels the antitumor effects. These findings define DHCR24 acetylation as a metabolic switch linking sterol synthesis to oncogenesis and highlight the DHCR24-7-ketocholesterol-p62 axis as a therapeutic target for HCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsKetocholesterolsOxidoreductases Acting on CH-CH Group DonorsProtein Processing, Post-TranslationalSterolsHumansAnimalsAcetylationMiceCell Line, TumorCell ProliferationMaleNerve Tissue Proteins

Stichwörter der Autor:innen

7-ketocholesterolCP: cancerDHCR24 acetylationcholesterol metabolismhepatocellular carcinomairbesartanp62-autophagy axistargeted therapy

Substanzen

Ketocholesterols7-ketocholesterolOxidoreductases Acting on CH-CH Group DonorsDHCR24 protein, humanSterolsNerve Tissue Proteins

Autor:innen und Institutionen

  • NHC Key Laboratory of Molecular Probes and Targeted Diagnosis and Therapy, The Fourth Hospital of Harbin Medical University, Harbin, China.
  • Precision Medical Center, Department of Pathology, Harbin Medical University Cancer Hospital, Harbin, China.
  • Basic Medical College of Heilongjiang University of Chinese Medicine, Harbin, China.
  • NHC Key Laboratory of Molecular Probes and Targeted Diagnosis and Therapy, The Fourth Hospital of Harbin Medical University, Harbin, China; Department of Infectious Disease, The Fourth Hospital of Harbin Medical Univers…
  • Department of Infectious Disease, The Fourth Hospital of Harbin Medical University, Harbin, China.
  • Key Laboratory of Molecular Oncology of Heilongjiang Province, Scientific Research Center, Harbin Medical University Cancer Hospital, Harbin, China. Electronic address: gengfeng@hrbmu.edu.cn.

Förderung

  • National Natural Science Foundation of China
  • Harbin Medical University
  • Ministry of Human Resources and Social Security of the People's Republic of China
  • Harbin Medical University Cancer Hospital

Zitieren

APA

Zhou, Y., Yang, X., Xu, J., Wu, Y., Fu, Y., Dong, Y., Yang, X., Fu, Q., Guo, C., Hou, Y., Chang, S., Yan, J., Ran, J., Wang, Y., Zhang, Q., Ayaka, T., Yu, L., Geng, F., Zhao, L., …, & Liu, D. (2025). Post-translational switch of DHCR24 acetylation sustains sterol synthesis and promotes HCC via the 7-ketocholesterol/p62 axis. Cell Reports. https://doi.org/10.1016/j.celrep.2025.116640

Vancouver

Zhou Y, Yang X, Xu J, Wu Y, Fu Y, Dong Y, et al. Post-translational switch of DHCR24 acetylation sustains sterol synthesis and promotes HCC via the 7-ketocholesterol/p62 axis. Cell Reports. 2025. doi:10.1016/j.celrep.2025.116640

BibTeX
@article{Zhou2025,
  author = {Zhou, Yunfei and Yang, Xinxin and Xu, Jianwen and Wu, Yidi and Fu, Yin and Dong, Yihong and Yang, Xun and Fu, Qiang and Guo, Chenxu and Hou, Yunjing and Chang, Shuyuan and Yan, Jun and Ran, Ju and Wang, Yumeng and Zhang, Qingxin and Ayaka, Tomii and Yu, Lei and Geng, Feng and Zhao, Liuyang and Hu, Xiaoyang and Li, Shuijie and Meng, Hongxue and Liu, Dabin},
  title = {Post-translational switch of DHCR24 acetylation sustains sterol synthesis and promotes HCC via the 7-ketocholesterol/p62 axis},
  journal = {Cell Reports},
  year = {2025},
  doi = {10.1016/j.celrep.2025.116640}
}
Kostenlos starten →